Clinical Trials Browser

Phase 2/3 × OTHER × Nasopharyngeal Neoplasms × Clear all

NCT01689558 2013-03-12

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Phase 2/3 Unknown

Nasopharyngeal Neoplasms